F
Fangbao Ding
Researcher at Shanghai Jiao Tong University
Publications - 64
Citations - 782
Fangbao Ding is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Atrial fibrillation & Lung cancer. The author has an hindex of 15, co-authored 59 publications receiving 596 citations.
Papers
More filters
Journal ArticleDOI
miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells
TL;DR: Preliminary evidence is provided that miR-342-3p acts as a tumor suppressor in NSCLC through repression of RAP2B through interactions with its 3′-UTR region.
Journal ArticleDOI
MicroRNA-30e-5p suppresses non-small cell lung cancer tumorigenesis by regulating USP22-mediated Sirt1/JAK/STAT3 signaling.
TL;DR: Findings suggest that miR‐30e‐5p suppresses NSCLC tumorigenesis by downregulating USP22‐mediated Sirt1/JAK/STAT3 signaling.
Journal ArticleDOI
The role of the ubiquitin-proteasome pathway in cancer development and treatment.
TL;DR: The current review focuses on the role of the UPS in cancer development and the development of UPS inhibitors for cancer treatment.
Journal ArticleDOI
The USP21/YY1/SNHG16 axis contributes to tumor proliferation, migration, and invasion of non-small-cell lung cancer.
Pei Xu,Haibo Xiao,Qi Yang,Rui Hu,Lianyong Jiang,Rui Bi,Xueyan Jiang,Lei Wang,Ju Mei,Fangbao Ding,Huang Jianbing +10 more
TL;DR: It is shown how an enzyme called USP21 promotes cancer cell proliferation and tumor growth in non-small-cell lung cancer, and the USP 21/YY1/SNHG16/miR-4500 axis plays a role in promoting the progression of NSCLC.
Journal Article
miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN
TL;DR: This study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression, and provided novel insights with potential therapeutic applications for the treatment ofNSCLC.